큐라티스
Adjuvant Platform Technology
  • Adjuvant is a substance used in combination with an antigen to enhance the in vivo cellular and humoral immune response to a particular antigen.
  • Alum, which was developed over 70 years ago, is the most widely used immune enhancer used in commercial vaccines.
  • In recent years, many researches have been achieved on innate immunity, and an innate immunity enhancer is being used as an adjuvant.
  • Thus, the adjuvant can be used as a vaccine for various diseases by replacing only specific antigens, and we are working on applying them to various fields.
Developing Advanced Formulations for Adjuvant
Developing Next-generation Adjuvant
Cell Therapy Platform Technology
  • Present in the lymphatic system and intercellular spaces of various tissues, dendritic cells (DCs) are antigen presenting cells (APCs) having strong antigen-presenting abilities.
  • DCs may either stimulate or regulate immunity, depending on the differentiating environment.
  • Treatment using DC platform can minimize side effects because they are able to control antigen-specific immunity differently from conventional drugs.
  • In our company, we are in the process of applying a cell therapy agent to intractable diseases, based on the technology of modulating the function of DCs.